Skip to content
Search

Latest Stories

MHRA drug alert for Finasteride 5mg tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) today issued a class 4 drug alert for 30 batches of Finasteride 5mg tablets.

Dr Reddy’s Laboratories (UK) has informed the government agency that Patient Information Leaflet (PIL) for these batches is missing the special warning precautions identified from post-marketing experience that is documented in the Summary of Product Characteristics (SmPC).


The change concerns the addition of the following in Section 4.4 Special warnings and precautions for use: “Mood alterations and depression: Mood alterations including depressed mood, depression and, less frequently, suicidal ideation have been reported in patients treated with finasteride 5 mg. Patients should be monitored for psychiatric symptoms and if these occur, the patient should be advised to seek medical advice.”

Pharmacists are asked to ensure that the patients are aware of any missing information. Any patients who notice the symptoms must seek immediate medical advice.

Product details:

Batch NumberExpiry datePack SizeFirst Distributed
C706092Nov 20202821 Feb 2018
C706093Nov 20202821 Feb 2018
C706094Nov 20202819 Mar 2018
C706095Nov 20202801 May 2018
C800262Dec 20202819 Mar 2018
C800263Dec 20202819 Mar 2018
C800264Dec 20202819 Mar 2018
C800483Dec 20202801 May 2018
C800484Dec 20202819 Mar 2018
C800485Dec 20202801 May 2018
C800486Dec 20202806 Apr 2018
C800506Jan 20212810 May 2018
C800507Dec 20202806 Apr 2018
C800508Dec 20202810 May 2018
C800509Jan 20212810 May 2018
C800510Jan 20212801 May 2018
C804932Jun 20212820 Sep 2018
C804933Jun 20212820 Sep 2018
C804934Jun 20212810 Oct 2018
C804935Jun 20212820 Sep 2018
C804936Jun 20212820 Sep 2018
C804937Jun 20212820 Sep 2018
C804938Jun 20212820 Sep 2018
C804939Jun 20212816 Oct 2018
C804940Jun 20212831 Oct 2018
C804941Jun 20212831 Oct 2018
C806744Oct 20212818 Mar 2019
C806745Oct 20212818 Mar 2019
C806746Oct 20212818 Mar 2019
C806747Oct 20212818 Mar 2019

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less